Please Wait
Applying Filters...

Annual Sales of Exenatide reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Company Name Product Name Active Ingredient Main Therapeutic Indication Currency 2016 Revenue in Millions 2015 Revenue in Millions 2016 Revenue in Millions (USD) 2015 Revenue in Millions (USD) Sales Difference in Millions (USD) Growth (%)
Byetta Exenatide Diabetes USD 126 176 126 176 -50 -28%
Bydureon Exenatide Diabetes USD 584 574 584 574 10 2%